LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    EuropaBio response to the public consultation on EU Taxonomy Environmental Delegated Act

    04/05/2023

    OTHER

    EuropaBio supports the Commission’s intent in developing sustainable financing as part of the Green Deal and welcomes the opportunity to provide feedback on the draft Taxonomy Delegated Act for environmental objectives.

    The bioeconomy can play a significant role in contributing to the environmental objectives outlined in the draft Delegated Act and in particular the transition to a circular economy. Use of bio-based products can help accelerate the shift towards a sustainable circular bioeconomy, creating jobs and growth, and reducing dependence on fossil-based carbon and CO2 emissions.

    EuropaBio fully supports the sustainable sourcing of biomass, taking food security, land use and biodiversity loss into account. Biomass is a valuable resource, and many parameters need to be considered when assessing its use. In many cases, food and non-food uses of biomass are complementary. Efficient use of resources should be promoted.

    However, only including bio-waste and excluding the use of other renewable feedstock like primary biomass is unfounded. To tackle climate change, it is critical that we decrease using fossil resources, and therefore embrace renewable carbon from all types of sustainably sourced feedstock as alternatives. On this basis, EuropaBio would urge the Commission to take a more inclusive view of feedstocks eligible for sustainable financing mechanisms under this criterion, by for instance focusing on sustainable sourcing, rather than simply limiting feedstocks. This approach would promote the future innovation and investment in the bioeconomy and in doing so assist in the gradual further transition towards alternative feedstocks away from fossil.

    Enzymes are key enablers of the bioeconomy: they are bio-manufactured proteins that offer bio-based solutions and bring a broad range of sustainability benefits. They are used in small amounts, reduce energy consumption, are biodegradable and can replace chemicals harmful to humans and the environment. Enzymes can accelerate the degradation of biodegradable and compostable plastics. Therefore, exclusion of enzymes from use in plastic feedstocks would hinder enzyme-based innovation in plastics without bringing significant environmental benefits.

     

    Read our comments here: https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/13237-Sustainable-investment-EU-environmental-taxonomy/F3411694_en

    Share
    Communications Team
    Communications Team

    Related posts

    08/05/2026

    Technovative Solutions Ltd. joins EuropaBio: Advancing AI‑Driven and Sustainable Innovation in Biotechnology


    Read more
    23/04/2026

    ITRE’s recognition of the importance of biomanufacturing and of biotechnology as a horizontal enabling technology for Europe’s future in the European Competitiveness Fund


    Read more
    22/04/2026

    EuropaBio Consultation Response: Review of the EU Taxonomy Delegated Acts


    Read more

    Important links

    • Biodefence & Biosecurity in focus for EuropaBio with dedicated Task Force
    • ‘Consistency, cooperation and practicality are the watch words’. EuropaBio reacts to provisional agreement on the Critical Medicines Act

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.